Recent News

• 05.08.2025 - Organogenesis Holdings Inc. First Quarter of Fiscal Year 2025 Earnings Conference Call
• 05.08.2025 - Organogenesis Holdings Inc. First Quarter of Fiscal Year 2025 Earnings Conference Call
• 04.11.2025 - Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
• 04.11.2025 - Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
• 04.11.2025 - Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
• 04.07.2025 - Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
• 04.07.2025 - Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
• 04.07.2025 - Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
• 02.27.2025 - Organogenesis Holdings Inc. Fourth Quarter and Fiscal Year 2024 Earnings Conference Call
• 02.27.2025 - Organogenesis Holdings Inc. Fourth Quarter and Fiscal Year 2024 Earnings Conference Call

Recent Filings

• 03.27.2025 - 8-K Current report
• 03.27.2025 - EX-99.1 EX-99.1
• 03.17.2025 - 144 Report of proposed sale of securities
• 03.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2025 - 8-K Current report